The University of Melbourne
Fig1. v02.tiff (322.51 kB)

Genetic diversity among historical and contemporary clinical isolates of felid herpesvirus 1

Download (322.51 kB)
posted on 2016-09-05, 03:26 authored by PAOLA VAZPAOLA VAZ, Natalie Job, Jacquelyn Horsington, Nino Ficorilli, Michael Studdert, Carol Hartley, James Gilkerson, GLENN BROWNINGGLENN BROWNING, JOANNE DEVLINJOANNE DEVLIN

This study used next generation sequencing to compare the genomes of contemporary Australian clinical isolates of FHV-1, vaccine isolates and historical clinical isolates, including isolates that predated the introduction of live attenuated vaccines into Australia. Analysis of the genome sequences aimed to assess the level of genetic diversity, identify potential genetic markers that could influence the in vivo phenotype of the isolates and examine the sequences for evidence of recombination.

The full genome sequences of 26 isolates of FHV-1 were determined, including two vaccine isolates and 24 clinical isolates that were collected over a period of approximately 40 years. Analysis of the genome sequences revealed a remarkably low level of diversity (0.0 - 0.01%) between the isolates. No potential genetic determinants of virulence were identified, but unique single nucleotide polymorphisms (SNPs) in the UL28 and UL44 genes were detected in the vaccine isolates that were not present in the clinical isolates. No evidence of FHV-1 recombination was detected using multiple methods of recombination detection, even though many of the isolates originated from cats housed in a shelter environment where high infective pressures were likely to exist. Evidence of displacement of dominant FHV-1 isolates with other (genetically distinct) FHV-1 isolates over time was observed amongst the isolates obtained from the shelter-housed animals.

Conclusions: The results show that FHV-1 genomes are highly conserved. The lack of recombination detected in the FHV-1 genomes suggests that the risk of attenuated vaccines recombining to generate virulent field viruses is lower than has been suggested for some other herpesviruses. The SNPs detected only in the vaccine isolates offer the potential to develop PCR-based methods of differentiating vaccine and clinical isolates of FHV-1 in order to facilitate future epidemiological studies.


The Australian Research Council (ARC DP130103991) and the Feline Health Research Fund supported this work. JMD is supported by ARC FT140101287.